Several of these studies have identified significant pathways and regulators that are modulated in HMCLs upon EZH2 inhibition including contextually relevant oncogenes/tumor suppressors [29, 31, 32, 34], novel miRNAs [31], cell-to-cell adhesion/mobility [29] and dysregulation of cell cycle control [33]. Here, EZH2 is linked to neoplasm.